To validate the role of the loss of SHH induced by hypermethylation in the determination of the molecular subtype of human bladder cancer, we examined 10 muscle-invasive urothelial carcinoma samples derived from patients (Table 1). The gene discussed is SHH; the disease is urinary bladder cancer.